Drug shrinks tumors to enable Life-Saving kidney surgery
NCT ID NCT03438708
Summary
This study is testing if taking the drug axitinib before surgery can shrink complex kidney tumors, making a kidney-sparing operation possible for patients who otherwise couldn't have it. The goal is to see if this approach is safe and helps surgeons successfully remove tumors while preserving more kidney function. The trial is enrolling 22 patients with a specific type of kidney cancer who need a partial kidney removal but currently face high surgical risks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLEAR CELL RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
UC San Diego Moores Cancer Center
La Jolla, California, 92093, United States
Conditions
Explore the condition pages connected to this study.